Novo Nordisk has launched blockbuster bodyweight-reduction drug Wegovy in Germany, its initially major European industry, hoping Germans can pay many euros outside of pocket for the drug that public wellbeing insurance plan designs are up to now barred from covering.Division stores and malls which include Galeria Kaufhof and Königsallee supply sup